UG stock icon



Market Cap: 53.3M


About: United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Employees: 25

Funds holding %
of 6,702 funds
Analysts bullish %
News positive %
of 3 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

7% more capital invested

Capital invested by funds: $7.66M [Q4 2023] → $8.19M (+$533K) [Q1 2024]

0.11% more ownership

Funds ownership: 23.16% [Q4 2023] → 23.27% (+0.11%) [Q1 2024]

0% more funds holding

Funds holding: 29 [Q4 2023] → 29 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Research analyst outlook

We haven’t received any recent analyst ratings for UG.

Financial journalist opinion

Based on 3 articles about UG published over the past 30 days